Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Moodys
Cantor Fitzgerald
Boehringer Ingelheim
Medtronic
Mallinckrodt
UBS
Cipla

Generated: July 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,550,165

« Back to Dashboard

Summary for Patent: 5,550,165
Title: Pharmaceutical compositions for the treatment of hereditary tyosinemia type I
Abstract:The invention concerns novel pharmaceutical compositions containing as an active ingredient a 2-benzoyl-1,3-cyclohexanedione which is an inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD). The compositions are valuable in the treating those disorders and diseases in which it is desirable to intervene in the metabolic sequences catalysed by HPPD, such as in treating tyrosinemia type I.
Inventor(s): Ellis; Martin K. (Macclesfield, GB2), Lindstedt; Sven T. (Lund, SE), Lock; Edward A. (Wilmslow, GB2), Markstedt; Maj E. H. (Billdal, SE), Mutter; Linda C. (Bloomfield, CA), Prisbylla; Michael P. (Richmond, CA)
Assignee: Zeneca Limited (London, GB2)
Application Number:08/359,361
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Formulation; Dosage form;

Drugs Protected by US Patent 5,550,165

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,550,165

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9113622Jun 24, 1991
United Kingdom9206412Mar 24, 1992

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Mallinckrodt
Federal Trade Commission
Chinese Patent Office
Accenture
US Army
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.